Verastem Inc. (NASDAQ: VSTM) Attends 31st Annual ROTH Conference
Verastem (NASDAQ: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Verastem is driven to deliver new therapies that not only keep cancer at bay but improve the lives of patients diagnosed with cancer. The company’s first FDA approved product is now available for the treatment of patients with certain types of indolent non-Hodgkin’s lymphoma (iNHL). Verastem’s pipeline comprises product candidates that seek to treat cancer by modulating the local tumor microenvironment. For more information, visit the company's website at www.verastem.com. About NetworkNewsWire NetworkNewsWire (NNW) is…







